The Canadian COVID‑19 Funded Research Database

University of British Columbia

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 31 through 40 of 68 results (Download Results)

Show results per page

COVID-19 Variant Network – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

Cherkasov, Artem | University of British Columbia | Operating Grant | $90,000

CIHR British Columbia 2021

COVID-19 Variant Supplement – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

Cherkasov, Artem | University of British Columbia | Operating Grant | $60,000

CIHR British Columbia 2021

COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases

Strynadka, Natalie C | University of British Columbia | Operating Grant | $100,000

CIHR British Columbia 2021

Utilizing Health System Data to Respond to COVID‑19 in Seven Resource Poor Countries

Law, Michael R | University of British Columbia | Operating Grant | $341,941

CIHR British Columbia 2020

Sex as a Biological Variable Supplement – Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease

Cherkasov, Artem | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2020

HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION – IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)

Russell, James A | University of British Columbia | Operating Grant | $3,456,541

CIHR British Columbia 2020

Host cellular protein substrates of SARS-CoV-2 proteases

Jan, Eric | University of British Columbia | Operating Grant | $331,212

CIHR British Columbia 2020

Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease

Cherkasov, Artem | University of British Columbia | Operating Grant | $999,000

CIHR British Columbia 2020

Sex as a Biological Variable Supplement – Host cellular protein substrates of SARS-CoV-2 proteases

Jan, Eric | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2020

The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection

Mui, Alice L | University of British Columbia | Operating Grant | $150,072

CIHR British Columbia 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Network – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

COVID-19 Variant Supplement – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases

Utilizing Health System Data to Respond to COVID‑19 in Seven Resource Poor Countries

Sex as a Biological Variable Supplement – Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease

HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION – IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)

Host cellular protein substrates of SARS-CoV-2 proteases

Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease

Sex as a Biological Variable Supplement – Host cellular protein substrates of SARS-CoV-2 proteases

The role of interleukin-10 responsiveness in lung inflammation in SARS CoV2 infection